跳至主要内容
临床试验/EUCTR2009-010145-31-DE
EUCTR2009-010145-31-DE进行中(未招募)不适用

A phase IV, open-label, multi-center follow-up study to determine the persistence of tick-borne encephalitis (TBE)-specific antibody responses among children and adolescents previously immunized against TBE. - M48P3E1

ovartis Vaccines and Diagnostics GmbH & Co. KG0 个研究点开始时间: 2009年2月17日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Healthy M48P3 study subjects with parental or legal guardian informed consent (health status as determined by review of medical history and physical examination and in the clinical judgment of the investigator)
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Subjects who did not receive complete schedule of primary vaccination in M48P3.
  • Subjects enrolled in other investigational studies at the same time and within the last three months
  • Subjects with any condition which, in the opinion of the investigator, might interfere with the evaluation of the study objectives

研究者

发起方
ovartis Vaccines and Diagnostics GmbH & Co. KG

相似试验